tirzepatide vs semaglutide fatigue vs. Ozempic: Comparing Diabetes Treatments & Weight Loss Benefits The 2026 Brandon GLP-1 Report:

Although Ozempic contains the same active ingredient found in some weight loss medications, it is solely approved for diabetes management and not for weight loss

Comprehensive overview of pharmacology, dosing, and clinical use

Other side effects, like constipation or muscle loss, may also occur but can be managed or prevented with lifestyle changes and personalized dosing like we offer in our clinics

Tesamorelin (Egrifta) is FDA-approved for HIV-associated lipodystrophy

Compounded tirzepatide is not FDA-approved and may be prescribed only when medically appropriate through licensed 503A compounding pharmacies based on an individual prescription and provider evaluation